By Admin · Sep 11, 2026
Your territory isn't growing. You've got stock, you've got documentation, you've made your rounds. So why aren't the repeat orders coming?
Indigammy is a derma PCD franchise company in India, and this covers the five most common reasons a territory stalls, and what actually fixes each one.
A prescriber handed twenty options remembers none of them. A prescriber handed two, with a clear reason to try each, remembers both. Pull back to two or three formulations from Indigammy's topical dermatology range, get those moving, then expand.
Reactive outreach, visiting whoever's available instead of whoever's relevant, wastes your most valuable early weeks. Before another sales call, list every dermatology clinic and pharmacy in your area, rank them by likely patient volume, and work that list deliberately.
Prescribers reference materials long after you leave the room. If your literature is generic, or something you wrote yourself under time pressure, it's not reinforcing anything once you're gone. Ask directly whether ready-made materials are actually included in your franchise support.
Total revenue tells you almost nothing in month one, it lags everything else by weeks. What matters now: which formulations are generating repeat interest, which prescribers are moving from introduction to actual prescribing, and how your stock compares to real movement.
The initial stock order gets all the planning attention. The working capital needed to sustain the next two or three months gets ignored, and that's exactly when partners hit a wall. Set aside capital for at least two additional reorder cycles before you start.
A territory that corrects even two or three of these issues usually sees a visible shift within a month. Prescribers who seemed lukewarm start asking follow-up questions. Reorders that weren't happening start showing up.
A cream that moves fast in one city might sit untouched in another, and that's a local demand pattern, not a formulation flaw. Indigammy's range spans both antifungal treatments and cosmetic formulations, giving you room to pivot once real data tells you what your prescribers actually want.
Every prescriber quietly evaluates two things: did your information hold up, and did your stock arrive when promised. Fail either, and you're rebuilding credibility instead of growing on it.
By day thirty, you should have logged real conversations with at least ten prescribers. By day sixty, several should have converted into actual prescriptions. By day ninety, a repeat pattern should be visible. If none of these hit, don't wait for month four.
Ten prescribers who genuinely trust you outperform fifty who met you once. Build depth first. Breadth comes naturally once trust is established.
A drug license sitting incomplete for two extra weeks delays your first order, your first real conversation, and your first revenue. Treat it as urgent from day one.
Anyone can handle a smooth first order. The real signal is whether that same responsiveness holds up once you're no longer the newest partner on the list.
Partners who start narrow sometimes end up representing Indigammy's full derma and cosmetic range within a year, because early discipline created room to expand.
Ask directly: what happens on the exact day my first order ships? A company with a specific name and a real timeline is showing you how your first ninety days will actually run. That single answer tells you more than any brochure or promotional call.
Pick your two hero formulations. Get your territory map on paper. Start tracking the three numbers that actually matter. Indigammy is a derma PCD franchise company in India built to support partners through exactly this diagnostic process.